kwd 2131 has been researched along with Anaphylaxis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nilsson, E; Ryrfeldt, A | 1 |
| Pegelow, KO; Persson, CG; Sörenby, L; Strandberg, K | 1 |
2 other study(ies) available for kwd 2131 and Anaphylaxis
| Article | Year |
|---|---|
Lung uptake and antianaphylactic effects of KWD 2131 (a beta-adrenergic agonist) in perfused guinea-pig lungs.
Topics: Adrenergic beta-Agonists; Anaphylaxis; Animals; Guinea Pigs; Histamine Release; In Vitro Techniques; Lung; Male; Perfusion; Pulmonary Circulation; Terbutaline | 1981 |
Anti-anaphylactic and bronchodilating action of a beta-adrenoceptor stimulator, KWD 2131, in human lung tissue.
Topics: Adrenergic beta-Agonists; Allergens; Anaphylaxis; Bronchi; Bronchodilator Agents; Ethanolamines; Histamine Release; Humans; In Vitro Techniques; Isoproterenol; Lung; Pollen; Terbutaline | 1979 |